Jordt Raymond M has filed 30 insider transactions across 1 company since January 2023.
Most recent transaction: a grant/award of 4571 shares of Altimmune, Inc. ($ALT) on January 31, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 31, 2026 | Altimmune, Inc. | $ALT | Jordt Raymond M | Chief Business Officer | A | Common Stock, par value $0.0001 | 4571 | $3.07 | 70,107.0000 | 88,104,132 | 6.97% | 0.01% |
| Jan. 27, 2026 | Altimmune, Inc. | $ALT | Jordt Raymond M | Chief Business Officer | M | Restricted Stock Units | 15850 | $0.00 | 47,550.0000 | 88,104,132 | 25.00% | 0.02% |
| Jan. 27, 2026 | Altimmune, Inc. | $ALT | Jordt Raymond M | Chief Business Officer | F | Common Stock, par value $0.0001 | 4229 | $6.18 | 65,536.0000 | 88,104,132 | 6.06% | 0.00% |
| Jan. 27, 2026 | Altimmune, Inc. | $ALT | Jordt Raymond M | Chief Business Officer | M | Common Stock, par value $0.0001 | 15850 | $0.00 | 69,765.0000 | 88,104,132 | 29.40% | 0.02% |
| Jan. 25, 2026 | Altimmune, Inc. | $ALT | Jordt Raymond M | Chief Business Officer | F | Common Stock, par value $0.0001 | 3855 | $5.50 | 53,915.0000 | 88,104,132 | 6.67% | 0.00% |
| Jan. 25, 2026 | Altimmune, Inc. | $ALT | Jordt Raymond M | Chief Business Officer | M | Restricted Stock Units | 14600 | $0.00 | 29,200.0000 | 88,104,132 | 33.33% | 0.02% |
| Jan. 25, 2026 | Altimmune, Inc. | $ALT | Jordt Raymond M | Chief Business Officer | M | Common Stock, par value $0.0001 | 14600 | $0.00 | 57,770.0000 | 88,104,132 | 33.82% | 0.02% |
| Jan. 1, 2026 | Altimmune, Inc. | $ALT | Jordt Raymond M | Chief Business Officer | F | Common Stock, par value $0.0001 | 2475 | $3.61 | 43,170.0000 | 88,104,132 | 5.42% | 0.00% |
| Jan. 1, 2026 | Altimmune, Inc. | $ALT | Jordt Raymond M | Chief Business Officer | M | Restricted Stock Units | 9375 | $0.00 | 9,375.0000 | 88,104,132 | 50.00% | 0.01% |
| Jan. 1, 2026 | Altimmune, Inc. | $ALT | Jordt Raymond M | Chief Business Officer | M | Common Stock, par value $0.0001 | 9375 | $0.00 | 45,645.0000 | 88,104,132 | 25.85% | 0.01% |
| July 31, 2025 | Altimmune, Inc. | $ALT | Jordt Raymond M | Chief Business Officer | A | Common Stock, par value $0.0001 | 1368 | $3.14 | 36,270.0000 | 81,477,548 | 3.92% | 0.00% |
| Jan. 31, 2025 | Altimmune, Inc. | $ALT | Jordt Raymond M | Chief Business Officer | A | Common Stock, par value $0.0001 | 2614 | $5.18 | 34,902.0000 | 71,003,399 | 8.10% | 0.00% |
| Jan. 27, 2025 | Altimmune, Inc. | $ALT | Jordt Raymond M | Chief Business Officer | A | Restricted Stock Units | 63400 | $0.00 | 63,400.0000 | 71,003,399 | 9999.99% | 0.09% |
| Jan. 25, 2025 | Altimmune, Inc. | $ALT | Jordt Raymond M | Chief Business Officer | M | Common Stock, par value $0.0001 | 14600 | $0.00 | 36,150.0000 | 71,003,399 | 67.75% | 0.02% |
| Jan. 25, 2025 | Altimmune, Inc. | $ALT | Jordt Raymond M | Chief Business Officer | F | Common Stock, par value $0.0001 | 3862 | $6.98 | 32,288.0000 | 71,003,399 | 10.68% | 0.01% |
| Jan. 25, 2025 | Altimmune, Inc. | $ALT | Jordt Raymond M | Chief Business Officer | M | Restricted Stock Units | 14600 | $0.00 | 43,800.0000 | 71,003,399 | 50.00% | 0.02% |
| Jan. 27, 2025 | Altimmune, Inc. | $ALT | Jordt Raymond M | Chief Business Officer | A | Stock Options (option to buy) | 183600 | $0.00 | 183,600.0000 | 71,003,399 | 9999.99% | 0.26% |
| Jan. 1, 2025 | Altimmune, Inc. | $ALT | Jordt Raymond M | Chief Business Officer | F | Common Stock, par value $0.0001 | 2485 | $7.21 | 21,550.0000 | 71,003,399 | 10.34% | 0.00% |
| Jan. 1, 2025 | Altimmune, Inc. | $ALT | Jordt Raymond M | Chief Business Officer | M | Common Stock, par value $0.0001 | 9375 | $0.00 | 24,035.0000 | 71,003,399 | 63.95% | 0.01% |
| Jan. 1, 2025 | Altimmune, Inc. | $ALT | Jordt Raymond M | Chief Business Officer | M | Restricted Stock Units | 9375 | $0.00 | 18,750.0000 | 71,003,399 | 33.33% | 0.01% |
| July 31, 2024 | Altimmune, Inc. | $ALT | Jordt Raymond M | Chief Business Officer | A | Common Stock, par value $0.0001 | 917 | $5.41 | 14,660.0000 | 70,924,371 | 6.67% | 0.00% |
| Jan. 31, 2024 | Altimmune, Inc. | $ALT | Jordt Raymond M | Chief Business Officer | A | Common Stock, par value $0.0001 | 5030 | $2.69 | 13,743.0000 | 53,246,937 | 57.73% | 0.01% |
| Jan. 25, 2024 | Altimmune, Inc. | $ALT | Jordt Raymond M | Chief Business Officer | A | Stock Options (option to buy) | 163200 | $0.00 | 163,200.0000 | 53,246,937 | 9999.99% | 0.31% |
| Jan. 25, 2024 | Altimmune, Inc. | $ALT | Jordt Raymond M | Chief Business Officer | A | Restricted Stock Units | 58400 | $0.00 | 58,400.0000 | 53,246,937 | 9999.99% | 0.11% |
| Jan. 1, 2024 | Altimmune, Inc. | $ALT | Jordt Raymond M | Chief Business Officer | M | Restricted Stock Units | 9375 | $0.00 | 28,125.0000 | 53,246,937 | 25.00% | 0.02% |
| Jan. 1, 2024 | Altimmune, Inc. | $ALT | Jordt Raymond M | Chief Business Officer | F | Common Stock, par value $0.0001 | 2503 | $11.25 | 8,704.0000 | 53,246,937 | 22.33% | 0.00% |
| Jan. 1, 2024 | Altimmune, Inc. | $ALT | Jordt Raymond M | Chief Business Officer | M | Common Stock, par value $0.0001 | 9375 | $0.00 | 11,207.0000 | 53,246,937 | 511.74% | 0.02% |
| July 31, 2023 | Altimmune, Inc. | $ALT | Jordt Raymond M | Chief Business Officer | A | Common Stock, par value $0.0001 | 1832 | $2.81 | 1,832.0000 | 50,691,558 | 9999.99% | 0.00% |
| Jan. 3, 2023 | Altimmune, Inc. | $ALT | Jordt Raymond M | Chief Business Officer | A | Restricted Stock Units | 37500 | $0.00 | 37,500.0000 | 46,926,349 | 9999.99% | 0.08% |
| Jan. 3, 2023 | Altimmune, Inc. | $ALT | Jordt Raymond M | Chief Business Officer | A | Stock Options (option to buy) | 125000 | $0.00 | 125,000.0000 | 46,926,349 | 9999.99% | 0.27% |